Helping Clinicians Interpret Genomics

Cambridge Precision Medicine helps clinicians interpret genomics with the objective of enabling their patients to live longer and happier lives. We manage and simplify the whole process of genetic screening, from sampling to report delivery. We believe in the benefit of Whole Genome Screening as a key instrument of preventative medicine; our particular expertise is in the interpretation of results, distilling an amount of data the equivalent of around ten million pages into a manageable report, focused on the clinicians' requirements and delivering actionable findings. Our results are not designed to be diagnostic in and of themselves. Indeed, the nature of genetics implies a risk-based approach to promoting wellness. Our findings are designed to be used by the clinician in conjunction with other information about the patient in order to generate hypotheses and treatment plans.

The Team

Manuel Corpas PhD, Chief Scientist

Manuel focused in the human genome since the very beginning of his career, being one of the first consumers to sequence and his own genome and those of close family members, which he published as the Corpasome. At the Sanger Institute in Cambridge, he developed methods for integration, visualisation and analysis of genomic data, and was also a Scientific Programmer at the European Bioinformatics Institute. In addition, he has lead research on animal and plant genome at the Genome Analysis Center and was Scientific Lead at Repositive, a start-up specialized in sharing and storing genomes of different types. As well as his work at Cambridge Precision Medicine, Manuel is a Tutor at the University of Cambridge Institute of Continuing Education and also teaches online courses in precision medicine in both English and Spanish.

Manuel has over 50 peer reviewed scientific publications to his name, and a book, ‘Perfect DNA’, in which he explores the wider issues beyond the science of genetic sequencing. He is a member of the scientific programme committee for the conference on Personal Genomes at the Welcome Genome Campus in Cambridge and is scientific coordinator of the Longevity World Forum in Valencia. Manuel graduated in Biomedical Sciences at the University of Navarra, with a Masters and PhD in Bioinformatics from the University of Manchester. Details of Manuel's publications can be found here.


Edmund Lehmann, Chief Executive

Ed set up and runs his own fund, investing in start up ventures where he has a particular interest and relevant experience to offer. He is an active member of the London Business Angels Network for angel investors. Ed spent most of his career in the energy industry, in commodities trading and business development at Shell and BG Group. He’s greatly enjoyed entrepreneurial roles he’s been lucky enough to hold, and developed expertise in adding the required commercial insights to technical teams.

Outside work, Ed is Chairman of the board of ReachOut, a mentoring charity helping to improve the lives of disadvantaged young people in inner cities in London, Manchester, Liverpool and Oldham. He is also an active supporter of the Roundhouse Trust. Ed holds the bilingual Masters in Business Administration from IESE Business School in Spain.


Collaborators

We work with experts in their field, typically based around the Cambridge genomics cluster, on areas where they have particular insight to bring to our customers, or the development of our company. All those we work with are highly qualified in their field and bring relevant experience to our projects. Biographies are available on request.


Antonio Metastasio, Clinical Board Member

Antonio trained as a doctor in Psychiatry in Cambridge. He completed a Masters degree in Neuroscience at the Institute of Psychiatry, King’s College London and most recently a Masters degree in Genomic Medicine at the University of Cambridge. He has a special interest in personalised medicine and genomics and in their application to psychiatry and addictions where he has developed a unique expertise; he has been pioneering the use of genetic tests in both research and clinical settings.

Antonio works as Consultant Psychiatrist in London at the Camden and Islington NHS Foundation Trust. He has been a senior clinical Tutor of the University of Cambridge and he is currently teaching medical students of the University College London. He also runs a private clinic at Cognacity 54 Harley Street, London and in Cambridge. He is a specialist in General Adult Psychiatry and in Addiction Psychiatry. He has an expertise in the main areas of adult psychiatry including depression, anxiety, obsessive compulsive disorder, bipolar affective disorder, stress related disorders, adjustment disorder ADHD and psychosis. He is also a specialist in the treatment of addictions including alcohol (dependence and binge drinking), substance misuse disorders (including legal highs) and behavioural addictions.